Financhill
Buy
56

CILJF Quote, Financials, Valuation and Earnings

Last price:
$3.45
Seasonality move :
5.09%
Day range:
$3.43 - $3.49
52-week range:
$1.35 - $3.81
Dividend yield:
3.61%
P/E ratio:
4.11x
P/S ratio:
1.35x
P/B ratio:
1.11x
Volume:
3.2K
Avg. volume:
9.5K
1-year change:
82.28%
Market cap:
$97.4B
Revenue:
$71.7B
EPS (TTM):
$0.84

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, China Life Insurance Co. Ltd. has -- downside to fair value with a price target of -- per share.

CILJF vs. S&P 500

  • Over the past 5 trading days, China Life Insurance Co. Ltd. has underperformed the S&P 500 by -3.26% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • China Life Insurance Co. Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • China Life Insurance Co. Ltd. has grown year-over-year revenues for 6 quarters straight. In the most recent quarter China Life Insurance Co. Ltd. reported revenues of $22.3B.

Earnings Growth

  • China Life Insurance Co. Ltd. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter China Life Insurance Co. Ltd. reported earnings per share of $0.63.
Enterprise value:
132.2B
EV / Invested capital:
--
Price / LTM sales:
1.35x
EV / EBIT:
5.20x
EV / Revenue:
1.84x
PEG ratio (5yr expected):
0.09x
EV / Free cash flow:
1.52x
Price / Operating cash flow:
1.12x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
2.46%
Net Income Margin (TTM):
33.44%
Return On Equity:
30.58%
Return On Invested Capital:
22.13%
Operating Margin:
6.06%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $56B $54.9B $71.9B $12.7B $22.3B
Gross Profit -- -- -- -- --
Operating Income $8.6B $21.5B $26.3B $10.4B $22.3B
EBITDA -- -- -- -- --
Diluted EPS $0.20 $0.58 $0.84 $0.33 $0.63
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $30.2B $108.7B $43.1B $357.6B $383.5B
Total Assets $731.3B $722.2B $787.6B $923.8B $1T
Current Liabilities $66.2B $45.2B $50.7B $22.4B $40.1B
Total Liabilities $657.3B $657B $725.8B $841.5B $952.4B
Total Equity $74B $65.2B $61.8B $82.3B $89.7B
Total Debt $8.5B $7.8B $6.7B $7B $5.1B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $77.8B $81.3B $87.2B $16B $20.6B
Cash From Investing -$79.1B -$84.7B -$88.4B -$22.2B -$20.3B
Cash From Financing $6.1B -$8B $4.2B $4.2B -$3.6B
Free Cash Flow $77.3B $80.6B $86.8B $16B $20.6B
CILJF
Sector
Market Cap
$97.4B
$554M
Price % of 52-Week High
90.42%
90.96%
Dividend Yield
3.61%
1.58%
Shareholder Yield
-0.7%
3.08%
1-Year Price Total Return
82.28%
6.77%
Beta (5-Year)
0.174
0.463
Dividend yield:
3.61%
Annualized payout:
$0.03
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $3.63
200-day SMA
Buy
Level $2.69
Bollinger Bands (100)
Buy
Level 2.9 - 3.48
Chaikin Money Flow
Buy
Level 14.6M
20-day SMA
Sell
Level $3.58
Relative Strength Index (RSI14)
Sell
Level 45.55
ADX Line
Sell
Level 11.16
Williams %R
Buy
Level -96.0526
50-day SMA
Buy
Level $3.44
MACD (12, 26)
Buy
Level 0.04
25-day Aroon Oscillator
Buy
Level 60
On Balance Volume
Neutral
Level 6.1M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.5206)
Sell
CA Score (Annual)
Level (-2.35)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.2255)
Buy
Piotroski F Score (Annual)
Level (8)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

China Life Insurance Co., Ltd. engages in the provision of life, annuity, accident, and health insurance. It operates through the following segments: Life Insurance Businesses, Health Insurance Businesses, Accident Insurance Businesses, and Other Businesses. The Life Insurance Businesses segment involves in the sale of life insurance policies, including those life insurance policies without significant insurance risk transferred. The Health Insurance Businesses segment offers health insurance policies, including those health insurance policies without significant insurance risk transferred. The Accident Insurance Businesses segment relates to the sale of accident insurance policies. The Other Businesses includes income and allocated cost of insurance agency businesses. The company was founded on November 23, 2003 and is headquartered in Beijing, China.

Stock Forecast FAQ

In the current month, CILJF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CILJF average analyst price target in the past 3 months is --.

  • Where Will China Life Insurance Co. Ltd. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that China Life Insurance Co. Ltd. share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About China Life Insurance Co. Ltd.?

    Analysts are divided on their view about China Life Insurance Co. Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that China Life Insurance Co. Ltd. is a Sell and believe this share price will rise from its current level to --.

  • What Is China Life Insurance Co. Ltd.'s Price Target?

    The price target for China Life Insurance Co. Ltd. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is CILJF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for China Life Insurance Co. Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of CILJF?

    You can purchase shares of China Life Insurance Co. Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase China Life Insurance Co. Ltd. shares.

  • What Is The China Life Insurance Co. Ltd. Share Price Today?

    China Life Insurance Co. Ltd. was last trading at $3.45 per share. This represents the most recent stock quote for China Life Insurance Co. Ltd.. Yesterday, China Life Insurance Co. Ltd. closed at $3.45 per share.

  • How To Buy China Life Insurance Co. Ltd. Stock Online?

    In order to purchase China Life Insurance Co. Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 2

Corcept Therapeutics, Inc. [CORT] is up 6.12% over the past day.

Buy
75
AXSM alert for Jan 2

Axsome Therapeutics, Inc. [AXSM] is down 3.13% over the past day.

Sell
50
NUTX alert for Jan 2

Nutex Health, Inc. [NUTX] is down 7.67% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock